Ballicules.com

Epinephrine

EPIPEN

What it isEndogenous catecholamine with alpha and beta agonism; anaphylaxis, cardiac arrest and severe asthma.

Why this oneIt is the only drug that treats every element of anaphylaxis at once.

What limits itIn anaphylaxis it is intramuscular into the thigh, and delay is the main cause of death — there is no reason to wait.

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Hypotension associated with septic shockadultIV infusion 0.05 mcg/kg/min0.05–2 mcg/kg/min, titrated to target MAP2 mcg/kg/min

Titration May adjust every 10–15 min in increments of 0.05–0.2 mcg/kg/min to reach target MAP.

Renal Undefined

Hepatic Undefined

Instructions

Cautions

Adverse reactions

Pregnancy Decades of use identify no drug-associated risk of major birth defects/miscarriage; do not delay treatment for shock.

Lactation Low milk transfer expected (poor oral bioavailability, short half-life); do not delay treatment.

NO BOXED WARNINGS

Principal riskDelay is the main cause of death in anaphylaxis

Cost, est. cash$30–$500/month

Generic entry1984

Classes and tags

Clinical profile

Therapeutic safety burden1 / 4
Overdose danger2 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk1 / 4

Legacy pregnancy categoryC

Defining liabilityTremor, tachycardia or anticholinergic effects; excessive beta-agonist exposure can cause hypokalemia and arrhythmia.

Mechanism of action: Epinephrine ballicule

Epinephrine ballicule: receptor binding, kinetics and half-life diagram

Open Epinephrine in the interactive console ↗